Musculoskeletal, Pulmonary, and Cardiovascular COVID-19 Sequelae in the Context of Firefighter Occupational Health: A Narrative Review

International Journal of Environmental Research and Public Health, Journal Year: 2024, Volume and Issue: 21(10), P. 1383 - 1383

Published: Oct. 19, 2024

For most individuals infected with SARS-CoV-2, the acute illness resolves completely. However, for millions of people, symptoms or sequelae from COVID-19 recur persist months to years after infection. Post-COVID-19 are wide-ranging, often affecting musculoskeletal, pulmonary, and cardiovascular systems. All who experience post-COVID-19 face significant challenges navigating home work life. Occupations such as firefighting, however, particular concern given strenuous nature a job that relies on healthy system. Research has documented musculoskeletal impairment (including muscle weakness, pain, fatigue), respiratory dysfunction reduced lung function, interstitial disease, diffusion abnormalities), conditions cardiac events, ischemic dysrhythmias, infectious diseases), diminished cardiorespiratory fitness continues in some individuals. These persistent may affect firefighter's ability return work, function at full capacity while potentially compromise firefighter health public safety. This review, therefore, explores impact these occupational readiness.

Language: Английский

Qualidade de Vida Relacionada à Saúde e Resultados em Longo Prazo após Covid-19 Levemente Sintomático: Explorando o Protocolo

Arquivos Brasileiros de Cardiologia, Journal Year: 2023, Volume and Issue: 120(9)

Published: Sept. 1, 2023

Mid-Regional Proadrenomedullin in COVID-19—May It Act as a Predictor of Prolonged Cardiovascular Complications?

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(23), P. 16821 - 16821

Published: Nov. 27, 2023

The rising prevalence of cardiovascular disease (CVD) and the impact SARS-CoV-2 pandemic have both led to increased mortality rates, affecting public health global economy. Therefore, it is essential find accessible, non-invasive prognostic markers capable identifying patients at high risk. One encouraging avenue exploration potential mid-regional proadrenomedullin (MR-proADM) as a biomarker in various conditions, especially context CVD COVID-19. MR-proADM presents ability predict mortality, heart failure, adverse outcomes CVD, offering promise for improved risk assessment treatment strategies. On other hand, an elevated level associated with severity cytokine storms COVID-19, making predictive indicator intensive care unit admissions rates. Moreover, may relevance long COVID, aiding assessment, triage, monitoring individuals developing prolonged cardiac issues. Our review explores predictor enduring complications following COVID-19 infection.

Language: Английский